Skip to main content
TipRanks
Go Ultimate75% OFF

Rocket Pharmaceuticals (RCKT) Ownership - Who Owns Rocket Pharmaceuticals?

1,734 Followers

Rocket Pharmaceuticals (RCKT) Ownership Overview

  • 20.40% Insiders
  • 15.84% Mutual Funds
  • 16.55% Other Institutional Investors
  • 12.48% ETFs
  • 34.72% Public Companies and Individual Investors

The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 44.88% of the company’s stock is owned by Institutional Investors, 20.40% is owned by Insiders, and 34.72% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 11, 2026Sarbani Chaudhuri$11,303
Nov 08, 2026Martin Wilson$127,600
Sep 14, 2026Martin Wilson$256,238
Aug 19, 2026Gaurav Shah$7,750

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026 $34,632,413

Top Shareholders

RCKT top shareholders
Holder# of SharesType% HoldingValue
Roderick Wong18,263,956Insider16.64%42,007,099
BlackRock, Inc.13,168,218Institution12.00%30,286,901
Ishares4,643,900Institution4.23%10,680,970
Vanguard4,628,957Institution4.22%10,646,601
Lee Ainslie3,923,963Institution3.57%9,025,115
Vanguard Index Funds3,701,156Institution3.37%8,512,659
Vanguard Horizon Funds2,702,086Institution2.46%6,214,798
Federated Hermes Mdt Series1,470,538Institution1.34%3,382,237
Gaurav Shah1,462,832Insider1.33%3,364,514
Fidelity Salem Street Trust1,115,893Institution1.02%2,566,554

Top Mutual Fund Holders

RCKT top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds3,701,156Institution3.37%8,512,659
Vanguard Horizon Funds2,702,086Institution2.46%6,214,798
Federated Hermes Mdt Series1,470,538Institution1.34%3,382,237
Fidelity Salem Street Trust1,115,893Institution1.02%2,566,554
Blackrock Funds968,263Institution0.88%2,227,005
Fidelity Concord Street Trust936,674Institution0.85%2,154,350
Bridge Builder Trust762,654Institution0.69%1,754,104
Vanguard Explorer Fund618,517Institution0.56%1,422,589
Vanguard Scottsdale Funds609,510Institution0.56%1,401,873
Dfa Investment Dimensions Group Inc524,181Institution0.48%1,205,616

Top ETF Holders

RCKT top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF2,700,288Institution2.42%7,101,757
iShares Russell 2000 ETF, IWM ETF2,377,252Institution2.13%5,467,680
Vanguard Extended Market ETF, VXF ETF1,046,936Institution0.94%2,753,442
Fidelity Enhanced Small Cap ETF, FESM ETF1,015,830Institution0.91%2,519,258
iShares Russell 2000 Value ETF, IWN ETF842,994Institution0.75%1,938,886
iShares Biotechnology ETF, IBB ETF817,689Institution0.73%1,880,685
Dimensional U.S. Small Cap ETF, DFAS ETF537,482Institution0.48%1,284,582
Vanguard Russell 2000 ETF, VTWO ETF526,282Institution0.47%1,384,122
Schwab U.S. Small-Cap ETF, SCHA ETF456,103Institution0.41%1,090,086
Invesco FTSE RAFI US 1500 Small-Mid ETF, PRFZ ETF284,961Institution0.26%655,410

FAQ

Who Owns Rocket Pharmaceuticals (RCKT)?
According to the latest TipRanks data, approximately 44.88% of the company's stock is held by institutional investors, 20.40% is held by insiders, and 34.72% is held by public companies and individual investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.88% of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors: 15.84% by mutual funds, 12.48% by ETFs and 16.55% by other institutional investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.72% of Rocket Pharmaceuticals (RCKT) stock is held by public companies and individual investors.
Who owns the most shares of Rocket Pharmaceuticals (RCKT)?
RODERICK WONG owns the most shares of Rocket Pharmaceuticals (RCKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.